indicate that IL-8, GCP-2, and ENA-78 equivalently reduced CXCR-1 and CXCR-2 cell surface expression by 34% to 54%. All treatments decreased affinity of both receptors 1.5-to 2-fold. However, only IL-8 pretreatment inhibited chemotaxis to 10-nmol/L IL-8 (mean ± SE inhibition, 62% ± 6%). Although IL-8 and GCP-2, but not ENA-78, suppressed TNF-␣-induced oxidant production (mean ± SE inhibition, 42% ± 8% and 40% ± 23%, respectively), only GCP-2 inhibited the oxidative response to complement fragment C5a, and to the bacterial cell wall peptide N-formyl-methionyl-leucylphenylalanine.
Conclusions:
The CXC chemokines regulate neutrophil proinflammatory functions differently. A thorough understanding of mechanisms for modulating neutrophil responses in inflammation will aid the development of interventions that reduce morbidity and mortality associated with severe trauma and sepsis.
Arch Surg. 1999; 134:1360 -1366 T HE INFLAMMATORY environment is composed of multiple soluble mediators that regulate neutrophil function, and accordingly dictate the character of the inflammatory response. These cytokines possess the ability to stimulate neutrophils and to specifically regulate neutrophil responses to resident cytokines. [1] [2] [3] [4] [5] This regulation imposed by resident cytokines is likely time and concentration dependent as well as stimulant specific.
Chemoattractant cytokines that are particularly important for neutrophil or polymorphonuclear leukocyte (PMN) proinflammatory functioning have 2 cysteine residues separated by a single amino acid in their N-terminal region and are therefore classified as CXC chemokines. 6 In contrast, the CC chemokines, which lack such separation, have no neutrophilstimulatory activity. The CXC chemokines share 30% to 90% amino acid sequence homology, with molecular weights ranging from 6 to 8 kd. Members of this family include interleukin 8 (IL-8); growth-related oncogene (GRO)␣, GRO␤, GRO␥; neutrophil-activating peptide-2 (NAP-2), granulocyte chemotactic protein 2 (GCP-2); and epithelial cellderived neutrophil attractant 78 (ENA-78). [7] [8] [9] [10] The chemokines induce neutrophil migration and secretion of cytotoxic granular contents and metabolites. Therefore, each may be important in neutrophil recruitment and activation in surgical inflammation. The differences in amino acid sequence and receptor-binding specificities, however, suggest that the CXC chemokines subserve important regulatory functions. Among the various chemokines, GCP-2 and IL-8 are functionally most similar, but share only 33% sequence similarity. In contrast, ENA-78 is 77% identical to GCP-2 but is functionally less similar than IL-8.
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Two pertussis toxin-sensitive, Gprotein-coupled CXC chemokine receptors have been identified on human neu- trophils, CXCR-1 and CXCR-2.
PAPER
12,13 These receptors are expressed at equal levels and share 32% sequence homology at the N-terminus and 77% over the rest of the protein. [14] [15] [16] The N-terminal region of the receptor is a key determinant of ligand specificity, although other important sites have been identified. [17] [18] [19] Of the neutrophil-activating chemokines, only IL-8 and GCP-2 induce neutrophil responses via CXCR-1. [20] [21] [22] On the other hand, ENA-78, GRO␣, NAP-2, IL-8, and GCP-2 induce neutrophil responses via CXCR-2 with similar efficacy (maximal chemotaxis or degranulation). 23 Originally isolated from osteosarcoma cells, GCP-2 is coproduced with IL-8, GRO␣, and ENA-78 in these cells. 11, 22, 23 Epithelial cell-derived neutophil attractant 78 was initially isolated from the conditioned medium of a human alveolar type II epithelial cell line. Like IL-8,
MATERIALS AND METHODS

PERIPHERAL BLOOD NEUTROPHIL ISOLATION AND PRETREATMENT WITH CHEMOKINES
Venous blood was drawn from healthy volunteers in syringes containing 0.25% EDTA (Sigma-Aldrich Corporation, St Louis, Mo). Blood cells were separated by dextran (Pharmacia, Columbus, Ohio) sedimentation and Ficoll histopaque (Ficoll-Hypaque; Sigma-Aldrich Corporation) density centrifugation as previously described. 30, 31 Neutrophil preparations were routinely greater than 95% pure with greater than 95% viability as assessed by trypan blue exclusion. For assays involving chemokine pretreatment, PMNs were pretreated at 1 ϫ 10 7 cells/mL in indicated concentrations of chemokines for 15 minutes at 37°C before subjection to various assays. Hanks buffered saline solution was used as a vehicle control.
MODIFIED BOYDEN CHAMBER CHEMOTAXIS
Neutrophils were treated with IL-8, GCP-2, or ENA-78 for 15 minutes at 37°C in Hanks buffered saline solution with 0.1% bovine serum albumin (Sigma-Aldrich Corporation). After washing, PMN migration to various concentrations of IL-8 was measured using a modified Boyden chamber chemotaxis assay, as previously described. 30 Neutrophils were allowed to migrate into a 5-µm micropore nitrocellulose filter (Neuroprobe) for 30 minutes at 37°C with 5% carbon dioxide before measuring the distance migrated by the leading front of cells.
FLOW CYTOMETRY ANALYSIS
Two million pretreated neutrophils were incubated with 1 µg of mouse monoclonal antibodies directed against human CXCR-1 or CXCR-2 (Pharmingen, San Diego, Calif ) or isotype control antibodies (Accurate Chemical & Scientific Corporation, Westbury, NY) for 20 minutes at 4°C. Next, the cells were incubated in 1 µg of fluorescentlabeled goat anti-mouse immunoglobulin (Kirkegaard and Perry Laboratories, Gaithersburg, Md) for 20 minutes at 4°C. After washing, neutrophils were resuspended in 1% paraformaldehyde and analyzed on a cytometer (Coulter Epics XL Flow Cytometer; Beckman Coulter, Inc, Fullerton, Calif ). I-GRO␣ concentrations remained constant at 1 nmol/L, whereas the unlabeled IL-8 or GRO␣ concentrations varied from 0 to 50 nmol/L. Duplicate tubes containing 2 ϫ 10 6 neutrophils were incubated 120 minutes at 4°C in 1-nmol/L radiolabeled chemokine with various concentrations of unlabeled homologous chemokine. Radioactivity of the cell pellets was counted in a gamma counter. Total receptors and dissociation constants (K d ) were determined by curve fitting to the Langmuire isotherm using commerically available software (Sigmaplot; Jandel Scientific, Inc, San Rafael, Calif ).
RADIOLIGAND BINDING ASSAY
ADHERENCE-DEPENDENT HYDROGEN PEROXIDE PRODUCTION
Ninety-six-well polystyrene tissue culture plates (Falcon-Primaria; Becton Dickinson Labware, Lincoln Park, NJ) were coated with 1 mg/well purified human plasma fibronectin (R&D) for 2 hours at 37°C and 5% carbon dioxide. Plates were washed with isotonic sodium chloride solution, then assay mix containing 0.5 mg of horseradish peroxidase, 1-mmol/L sodium azide, and 4 nmol of scopoletin in Krebs-Ringer solution with 0.1% glucose was added to the wells. The CXC chemokines were added to wells at a final concentration of 10 nmol/L. Polymorphonuclear leukocytes (1.5 ϫ 10 4 ) then were added to the wells and allowed to settle for 15 minutes before stimulation with 10-ng/mL TNF-␣, 10-nmol/L fMLP, or 10-nmol/L C5a. Hydrogen peroxide production was measured for 80 minutes as the decrease in fluorescence due to the oxidation of scopoletin. Tumor necrosis factor ␣ normally has a lag time of 40 to 50 minutes before hydrogen peroxide production is appreciable. For this reason, only the data from 60 to 80 minutes are reported and are expressed as percentage of decrease from the control cells pretreated with KrebsRinger solution with glucose.
MATHEMATICAL CALCULATIONS AND STATISTICAL ANALYSIS
In flow cytometry experiments, the mean channel fluorescence of chemokine-pretreated cells was expressed as a percentage of buffer-pretreated cells. In chemotaxis experiments, the data reported represent the total distance migrated to IL-8. The percentage of inhibition was calculated from total migration in buffer-and chemokine-treated cells. All summarized data are represented as mean ± SEM. Statistical analyses were performed using paired t tests and singlefactor analysis of variance.
ENA-78 also is produced by monocytes, endothelial cells, lung fibroblasts, and neutrophils. 24, 25 High steady state messenger RNA levels of GCP-2 and ENA-78 have also been detected in human heart and lung. 11 That these chemokines are derived from various cell types additionally supports the notion that chemokines are encountered by neutrophils in a temporally and/or spatially regulated manner as they migrate to sites of inflammation. However, it is also possible that neutrophils encounter chemokines concomitantly.
To date, considerable effort has been placed into identifying specialized functions of the individual CXC receptors. Results from such studies involving transfected cell lines reveal that each receptor is independently capable of mediating IL-8-induced chemotaxis. 26, 27 However, chemokine-specific regulation of PMN responses to various cytokines has not been identified. Several studies have shown that CXCR-2-specific ligands GRO␣ and NAP-2, but not IL-8 (which binds CXCR-1 and CXCR-2), potently suppress subsequent IL-8-induced degranulation, suggesting an important regulatory function of these ligands. 28, 29 Similar functions for other CXC chemokines remain to be characterized.
We reasoned that despite their similarities in structure, receptor binding, chemoattractant properties, and derivations, IL-8, GCP-2, and ENA-78 perform distinct regulatory functions. To test our hypothesis, we pretreated PMNs with IL-8, GCP-2, or the CXCR-2-specific chemokine ENA-78, and subsequently assesed chemotactic activity by measuring IL-8-induced migration. We also tested the ability of the CXC chemokines to modulate adherence-dependent oxidant production, an important event in neutrophil-mediated cytotoxicity and bactericidal activity. This response is mediated by receptors that bind tumor necrosis factor ␣ (TNF-␣), complement factor C5a, or the bacterial cell wall peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP). It therefore accommodates the examination of chemokine effects on a range of neutrophil stimulants. Our findings demonstrate that IL-8, but not GCP-2, desensitized PMN chemotactic responsiveness to IL-8. Although they suppressed TNF-␣-induced oxidant production with similar efficacy, only GCP-2 inhibited the oxidative response to C5a and fMLP. Like IL-8 and GCP-2, ENA-78 substantially reduced cell surface expression of CXCR-1 and CXCR-2, but had no effect on IL-8-induced migration or stimulant-induced oxidant production.
RESULTS
CXC CHEMOKINES DIFFERENTIALLY SUPPRESS IL-8 RESPONSIVENESS
We initially sought to determine the effects of IL-8, GCP-2, and ENA-78 on neutrophil responses to subsequent IL-8 challenge. To this end, we pretreated PMNs with GCP-2 and ENA-78 for 15 minutes at 37°C and measured chemotaxis to IL-8. Migration to IL-8 was unaffected by pretreatment with 100-nmol/L GCP-2 or ENA-78, whereas pretreatment with a 10-fold lower concentration of IL-8 inhibited the response to subsequent 1-or 10-nmol/L IL-8 challenge by 54% ± 3% and 62% ± 6%, respectively (Figure 1) . It has been speculated that as little as 20% of chemoattractant receptor occupancy is required to sustain chemotactic responsiveness. 32 It therefore remained possible that although these chemokines have no effect on migration to IL-8, they could substantially decrease cell surface CXC receptor expression and thereby affect other cell functions. To explore this possibility, we performed flow cytometry studies using antibodies directed against CXCR-1 and CXCR-2. Figure 2 shows a substantial reduction in CXCR-1 and CXCR-2 immunoreactivity following treatment with GCP-2, ENA-78, or IL-8. To quantify CXC receptor loss and to determine alterations in receptor affinity, we performed radioligand binding studies using I-GRO␣. Pretreatment with IL-8, GCP-2, or ENA-78 caused a 1.5-to 2-fold decrease in receptor affinity (Table) . show a greater decrease in CXCR-2 expression than is determined by radioligand binding results (approximately 50% and 20% losses, respectively). However, these differences were not statistically significant. The results from both assays demonstrate that loss of CXC receptors following GCP-2 or ENA-78 pretreatment is similar to that following IL-8 pretreatment, despite their inability to inhibit chemotaxis. This suggests that mechanisms other than receptor down-regulation are operative in IL-8 suppression of chemotaxis.
CXC RECEPTOR DOWN-REGULATION AND AFFINITY MODULATION
CXC CHEMOKINES DISPARATELY SUPPRESS OXIDANT PRODUCTION
Adherence-dependent oxidant production is a critical effector of PMN-mediated tissue injury. We therefore sought to assess whether these chemokines could regulate this important neutrophil response. Polymorphonuclear leukocytes were plated on fibronectin-coated tissue culture plates that contained IL-8, GCP-2, or ENA-78. Following a 15-minute incubation at 37°C, PMNs were stimulated with 10 ng/mL TNF-␣, 10-nmol/L fMLP, or 10-nmol/L C5a. Figure 4 shows GCP-2, but not ENA-78, suppressed hydrogen peroxide production in response to TNF-␣, fMLP, and C5a (40% ± 23%, 33% ± 11%, and 66% ± 14% inhibition, respectively). Interleukin 8 suppressed only the TNF-␣-induced response by 42% ± 8%.
COMMENT
It is generally accepted that neutrophils exist in the following 4 prominent populations: the circulating pool; the marginating pool, loosely tethered to microvasculature; the pool firmly adhered to endovasculature; and transmigrated neutrophils in the parenchyma. It is believed that the circulating and particularly the marginated pools provide an abundant source of neutrophils capable of being recruited rapidly to sites of injury or infection. After injury, neutrophils from these pools firmly attach to the endovasculature and migrate into the parachymal spaces, †PϽ.05 compared with buffer-treated groups, using the paired t test.
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Following traumatic injury or endotoxemia, plasma levels of several proinflammatory cytokines, including IL-8, are significantly elevated. [35] [36] [37] It is possible that elevated plasma IL-8 levels serve as a biological timer of neutrophil recruitment to inflammatory loci. The effects of an IL-8 concentration spike may be particularly important for the circulating and marginated neutrophil pools in that they potentially terminate neutrophil recruitment from these pools to sites of inflammation. We sought to examine this possibility by exposing suspension-phase neutrophils to IL-8 and measuring subsequent IL-8-induced migration.
At sites of inflammation, transmigrated neutrophils, presumably in an adherent phase, encounter a milieu of soluble mediators. Activated macrophages and epithelial cells present at the site produce several CXC chemokines in addition to IL-8. 24, 25 We therefore measured adherence-dependent oxidant production to assess the modulatory effects of various chemokines on this neutrophil population's responses to inflammatory stimuli.
We showed that pretreatment with IL-8, GCP-2, or ENA-78 causes substantial loss of cell surface CXCR-1 and CXCR-2 expression with concomitant decrease in receptor affinity. Pretreatment with 10-nmol/L IL-8, but not 100-nmol/L GCP-2 or ENA-78, resulted in ablation of migration to subsequent maximal stimulatory doses of IL-8 (10 nmol/L). The mechanisms involved in differential inhibition of IL-8-induced chemotaxis by these chemokines are currently unknown. However, homologous desensitization of the CXC receptors has been the subject of several recent investigations. The CXC receptors are desensitized by protein kinase C-dependent phosphorylation of the C-terminal region of the receptor. [38] [39] [40] Various stimulants, including fMLP, C5a, TNF-␣, and GCP-2, have been shown to desensitize IL-8-induced calcium transients. 1, 2, 11, 41 The finding that GCP-2 had no significant effect on IL-8-induced chemotaxis suggests that signaling for intracellular calcium elevation and chemotaxis are independently inhibitable.
We also present novel evidence that CXC chemokines suppress stimulant-induced oxidant production. Interleukin 8, ENA-78, and GRO␣ previously have been shown to enhance or to prime the oxidative response to stimulants such as fMLP.
14 Moreover, in suspensionphase neutrophils, some CXC chemokines are capable of inducing an oxidative response. 42, 43 Herein we show that IL-8 and GCP-2 inhibit TNF-␣-induced oxidant production, an adherence-dependent response. Granulocyte chemotactic protein 2, but not IL-8 or ENA-78, also inhibits C5a-and fMLP-induced oxidant production in adherent neutrophils. These findings further support the notion of receptor discrimination among different highaffinity ligands. Granulocyte chemotactic protein 2 and IL-8 in this instance have distinctly different regulatory effects on neutrophil responses to IL-8, C5a, and fMLP.
We propose that the CXC chemokines function within what we term a multiple ligand-single receptor regulatory system. The CXC chemokines, although competitively binding the same receptor(s), subserve independent and important regulatory functions. The data suggest that chemokine receptors discriminate between ligands and accordingly mediate ligand-specific responses. Despite reports that IL-8 and GCP-2 induce chemotaxis with similar efficacy, our data suggest that they disparately inhibit IL-8-induced chemotaxis. Although they equipotently decreased cell surface CXC receptor expression and TNF-␣-induced oxidant production, only GCP-2 inhibited C5a-or fMLP-induced oxidant production.
Broadly, our data suggest that the existence of multiple molecules that bind to the same promiscuous receptor permits ligand-specific regulation of cell re- 
Statement of Clinical Relevance
Acute respiratory distress syndrome has emerged as a leading cause of morbidity and mortality for trauma and burn patients with otherwise survivable injuries. Neutrophil recruitment and disordered oxidant production in the alveolar interstitium are believed to be central to the extracellular matrix destruction and cytotoxicity associated with this condition. We present evidence that, in addition to inducing neutrophil migration, select CXC chemokines induce important anti-inflammatory responses in neutrophils. In this connection, the CXC chemokines participate in the modulation of the inflammatory response. Interleukin 8 and GCP-2 inhibit adherence-dependent oxidant production. However, of the chemokines tested, only IL-8 desensitized neutrophil migration to subsequent IL-8 challenge. We believe that both of these inhibitory responses are mediated via only 1 of the 2 CXC receptors, CXCR-2. We previously showed that loss of CXCR-2 is commensurate with severity of traumatic injury. 44 Loss of CXCR-2-mediated regulation may be an important prognostic indicator in these patients. Moreover, our present findings suggest that anti-inflammatory drugs can be modeled after the chemokines to selectively inhibit chemotaxis and/or oxidant production by differentially activating CXCR-2.
ARCH SURG/ VOL 134, DEC 1999 sponses. The operation of such a multiple ligand-single receptor regulatory system in neutrophils allows the character of the inflammatory response to be coordinated temporally and spatially by the composition of the inflammatory milieu. We suspect that the CC chemokines, which similarly bind promiscuous receptors, differentially modulate monocyte and lymphocyte immune responses. Exploitation of the anti-inflammatory and immunosuppressive actions of these chemoattractant receptors may prove beneficial in the development of novel therapeutic interventions.
